The Bank of England's decision to raise its benchmark interest rate to 4 per cent could have implications for community pharmacies, from higher loan repayments and more expensive acquisitions to tighter cash flow and reduced investment.
The Monetary Policy Committee (MPC) voted 8-1 on 5 November to increase the Bank Rate by 25 basis points from 3.75 per cent. It was the first increase since August 2023, as the central bank responded to rising energy costs and the risk of inflation becoming more persistent.
One MPC member, Catherine Mann, voted for a larger increase to 4.25 per cent.
The Bank expects consumer price inflation to approach 5 per cent by mid-2027, largely because of higher energy prices linked to the conflict in the Middle East. Inflation stood at 3.5 per cent in September, above the Bank's 2 per cent target.
Governor Andrew Bailey said the increase should not be interpreted as the beginning of an inevitable series of rate rises, but warned that further increases could be necessary if the conflict continued.
For pharmacy owners, the decision matters because the Bank Rate influences the interest charged by commercial lenders. While the impact will depend on individual borrowing arrangements and how lenders adjust their products, businesses relying on credit could face higher financing costs.
How will higher interest rates affect pharmacy businesses?
Borrowing and cash flow
Pharmacies with variable-rate loans, overdrafts and other borrowing facilities could see their financing costs increase as lenders respond to the Bank Rate decision. The precise impact will depend on the terms of each facility.
This could be particularly relevant for independent contractors who use overdrafts or short-term finance to manage working capital.
Pharmacies need sufficient working capital to cover stock purchases, staff wages, supplier payments and other expenses while waiting for payments.
A higher cost of borrowing could make this gap more expensive to manage.
In an earlier Pharmacy Business article, Keeping on top of your cash flow, accountant Shivam Modi highlighted the importance of cash-flow forecasting, stock management and monitoring credit facilities for community pharmacies facing financial pressure.
Acquisitions and business valuations
The rate increase could also influence the cost of buying and selling pharmacies.
Many acquisitions rely on bank finance. If borrowing becomes more expensive, prospective buyers may have to account for higher repayment costs when deciding how much they can afford to pay for a business.
This could affect acquisition budgets, negotiations and the valuations buyers are prepared to accept. Owners considering retirement or selling their businesses may also need to consider how financing conditions affect potential purchasers.
The sector already faces pressure from rising overheads and tighter profitability. A previous Hutchings report on pharmacy contractors highlighted how staff wages, energy, utilities, rent and increased loan costs had put pressure on goodwill offers, while bank-funded acquisitions accounted for more than 95 per cent of transactions covered by its sales data.
Investment in technology and expansion
Pharmacy businesses planning to refurbish premises, install dispensing robots, upgrade technology or open additional branches could also face more expensive financing.
Higher borrowing costs can change the financial calculations behind long-term investments, particularly where the expected savings or additional income take time to materialise.
Some owners may decide to postpone projects, reduce their investment budgets or seek alternative financing arrangements.
This could have implications for the pace at which pharmacies adopt automation and expand their operations.
Inflation and operating expenses
The interest rate increase comes as pharmacies continue to manage higher operating costs.
The Bank expects inflation to approach 5 per cent by mid-2027, with energy prices a major factor. Higher fuel and utility costs can feed into supplier prices, transport expenses and other business overheads.
Pharmacies will also have to account for the National Living Wage rising to £13.21 an hour from April 2027, adding to staffing expenditure.
The challenge is that community pharmacies cannot necessarily pass these increases directly on to patients. Much of their income comes through nationally determined NHS funding arrangements, limiting their flexibility to raise prices to compensate for higher costs.
The combination of more expensive borrowing and rising operating expenses could therefore put further pressure on margins.
Consumer spending
Higher interest rates can also affect pharmacy income indirectly.
Households with mortgages, loans and other variable-rate borrowing may have less disposable income as repayments increase. This could lead some consumers to reduce discretionary spending.
For pharmacies, this may affect sales of over-the-counter products, beauty and personal care items, as well as private services such as weight management and travel vaccinations.
The extent of any impact will depend on household finances and local customer demand, but it is another factor pharmacy businesses may need to consider.
What can pharmacy owners do?
The rate increase will not affect every pharmacy in the same way. Businesses with variable-rate borrowing are more exposed to changes in lending costs, while those with fixed-rate loans will generally remain on their agreed terms until the deal expires.
Pharmacies holding cash reserves could also benefit from higher interest returns, depending on the savings products available and how banks adjust their rates.
Owners can review their existing borrowing arrangements to establish which facilities are linked to Bank Rate and when fixed-rate agreements are due for renewal. Those approaching the end of a fixed-rate deal may want to discuss refinancing options with their lenders early.
Regular cash-flow forecasting, tighter stock control and a review of planned capital expenditure can also help businesses prepare for higher financing and operating costs.
The Bank of England's next interest rate decision is scheduled for 17 December. Its future decisions will depend on developments in energy prices, inflation and the wider economy.
For pharmacies, the 4 per cent Bank Rate is not simply an economic indicator. It could influence the cost of keeping a business running, financing its next acquisition and investing in its future.
